{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EU ORPHAN DRUG" in comments (approximate match)
Status:
US Previously Marketed
Source:
Lactobacillus acidophilus
(1921)
Source URL:
First marketed in 1921
Source:
Lactobacillus acidophilus
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
Tincture of Saw Palmetto and Santal N.F.
(1921)
Source URL:
First marketed in 1921
Source:
Tincture of Saw Palmetto and Santal N.F.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125786
(2024)
Source URL:
First approved in 2024
Source:
BLA125786
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
ProBionexxProbiotic Support by SKYA HEALTH, LLC
(2023)
Source URL:
First approved in 2022
Source:
Degong Ling by Shenzhen Deyintang Biotechnology Co., Ltd.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125714
(2021)
Source URL:
First approved in 2021
Source:
BLA125714
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03117322: Phase 4 Interventional Completed Cerebral Palsy
(2017)
Source URL:
First approved in 2011
Source:
M020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT04118088: Phase 4 Interventional Terminated Crohn's Disease
(2020)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT01941745: Phase 2 Interventional Completed Respiratory Distress Syndrome in Premature Infant
(2013)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03669393: Phase 2 Interventional Completed Retinal Telangiectasis
(2018)
Source URL:
Class:
CONCEPT